Parminder K. Judge, PhD, explains why eGFR and electrolytes should be monitored when diuretics are added to reach intensive BP targets in patients with CKD
Commentary|Videos|April 13, 2026
How Antidoping Resources Support the Entire Athlete Care Team
Fact checked by: Ron Panarotti
Advertisement
In an interview with Pharmacy Times, Greta Neimanas, PLY, highlights the critical role of athlete support personnel—including pharmacists, providers, and even parents—in navigating antidoping regulations. She emphasizes the accessibility of key tools, such as Global DRO, a searchable database that helps users quickly determine whether medications are permitted, and Supplement Connect, which identifies risks associated with dietary supplements. Neimanas also points to HealthPro Advantage, a free, accredited e-learning course designed to educate health professionals on antidoping rules and best practices.
Advertisement
Related to this article
Pharmacy teams can prevent early discontinuation by setting clear expectations for when—and how—a medication's benefit will become apparent.
Experts on Lp(a) testing, statin myths, cognitive safety, and the 2025-2030 Dietary Guidelines share counseling points from the National Lipid Association's Fall Clinical Lipid Update meeting.
Eric Lawitz, MD, explains how pharmacists can discuss liver risk with patients with obesity and why a FIB-4 score from routine blood work is a good first step.
Pharmacogenomic-guided prescribing uses genetic data to protect patients from dangerous toxicities and get them the right drug at the right dose from the start.
The project maps how flu and HIV proteins enter cells, with the aim of developing longer-lasting vaccines.
VAX-31 met all primary end points against PCV20 and PCV21 in the pivotal phase 3 OPUS-1 trial.
A year after FDA approval in heart failure (HF) with LVEF of 40% or higher, new ACC guidance and trial subanalyses are shaping how pharmacists use finerenone.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Finerenone Expands MRA Options as Pharmacists Address Underrecognized HFpEF
2
Diuretics, eGFR, and Intensive BP Lowering in CKD: What to Watch
3
Finerenone in Heart Failure: Evidence and Practice a Year Later
4
Researchers Target Viral Fusion for Universal Flu, HIV Vaccines
5